June 4, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of New Fortress Energy, Inc. (“New Fortress” or “the Company”) (NASDAQ: NFE). Investors who purchased New Fortress securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
May 29, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of NeuroPace, Inc. (“NeuroPace” or “the Company”) (NASDAQ: NPCE). Investors who purchased NeuroPace securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether NeuroPace has violated federal… read more
May 28, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of AlloVir Inc. (“AlloVir” or “the Company”) (NASDAQ: ALVR). Investors who purchased AlloVir securities prior to March 22, 2022, and continue to hold to the present, are encouraged to obtain additional information… read more
May 27, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ADTRAN Holdings, Inc. (“ADTRAN” or “the Company”) (NASDAQ: ADTN). Investors who purchased ADTRAN securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether ADTRAN has violated… read more
May 26, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fulgent Genetics, Inc. (“Fulgent” or “the Company”) (NASDAQ: FLGT). Investors who purchased Fulgent securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Fulgent has violated… read more
May 26, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Flowco Holdings Inc. (“Flowco” or “the Company”) (NYSE: FLOC). Investors who purchased Flowco securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Flowco has violated… read more
May 22, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Schrödinger, Inc. (“Schrödinger” or “the Company”) (NASDAQ: SDGR). Investors who purchased Schrödinger securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Schrödinger has violated federal… read more
May 20, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Travere Therapeutics, Inc. (“Travere” or “the Company”) (NASDAQ: TVTX). Investors who purchased Travere securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Travere has violated… read more
May 19, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Meta Platforms, Inc. (“Meta” or “the Company”) (NASDAQ: META). Investors who purchased Meta securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Meta has violated… read more
May 19, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GoHealth, Inc. (“GoHealth” or “the Company”) (NASDAQ: GOCO). Investors who purchased GoHealth securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether GoHealth has violated federal… read more
May 16, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Metallus Inc. (“Metallus” or “the Company”) (NYSE: MTUS). Investors who purchased Metallus securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Metallus has violated federal… read more
May 16, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Integra LifeSciences Holdings Corporation (“Integra” or “the Company”) (NASDAQ: IART). Investors who purchased Integra securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Integra has… read more
May 16, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Senti Biosciences, Inc. (“Senti” or “the Company”) (NASDAQ: SNTI). Investors who purchased Senti securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Senti has violated… read more
May 15, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Bancorp, Inc. (“Bancorp” or “the Company”) (NASDAQ: TBBK). Investors who purchased Bancorp securities prior to January 25, 2024, and continue to hold to the present, are encouraged to obtain additional… read more
May 15, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Coinbase Global, Inc. (“Coinbase” or “the Company”) (NASDAQ: COIN). Investors who purchased Coinbase securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Coinbase has violated… read more
May 15, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Take-Two Interactive Software, Inc. (“Take-Two” or “the Company”) (NASDAQ: TTWO). Investors who purchased Take-Two securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Take-Two has… read more
May 14, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cleveland-Cliffs Inc. (“Cleveland-Cliffs” or “the Company”) (NYSE: CLF). Investors who purchased Cleveland-Cliffs securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Cleveland-Cliffs has violated federal… read more
May 13, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of EchoStar Corporation (“EchoStar” or “the Company”) (NASDAQ: SATS). Investors who purchased EchoStar securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether EchoStar has violated federal… read more
May 12, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Myriad Genetics, Inc. (“Myriad Genetics, Inc.” or “the Company”) (NASDAQ: MYGN). Investors who purchased Myriad Genetics, Inc. securities are encouraged to obtain additional information and assist the investigation. The investigation concerns… read more
May 12, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ichor Holdings, Ltd. (“Ichor” or “the Company”) (NASDAQ: ICHR). Investors who purchased Ichor securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Ichor has violated… read more
May 9, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of TaskUs, Inc. (“TaskUs” or “the Company”) (NASDAQ: TASK). Investors who purchased TaskUs securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether TaskUs has violated federal… read more
May 7, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cable One, Inc. (“Cable One” or “the Company”) (NYSE: CABO). Investors who purchased Cable One securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Cable… read more
May 7, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Watsco, Inc. (“Watsco” or “the Company”) (NYSE: WSO). Investors who purchased Watsco securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Watsco has violated federal… read more
May 7, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Jack in the Box Inc. (“Jack in the Box” or “the Company”) (NASDAQ: JACK). Investors who purchased Jack in the Box securities are encouraged to obtain additional information and assist the… read more
May 7, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Amerant Bancorp Inc. (“Amerant” or “the Company”) (NYSE: AMTB). Investors who purchased Amerant securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Amerant has violated… read more
May 6, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ready Capital Corporation (“Ready Capital” or “the Company”) (NYSE: RC). Investors who purchased Ready Capital securities prior to November 7, 2024, and continue to hold to the present, are encouraged to… read more
May 6, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PTC Therapeutics, Inc. (“PTC” or “the Company”) (NASDAQ: PTCT). Investors who purchased PTC securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether PTC has violated… read more
May 5, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Kohl’s Corporation (“Kohl’s” or “the Company”) (NYSE: KSS). Investors who purchased Kohl’s securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Kohl’s has violated federal… read more
May 2, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Arvinas, Inc. (“Arvinas” or “the Company”) (NASDAQ: ARVN). Investors who purchased Arvinas securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Arvinas has violated federal… read more
May 1, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Wabash National Corporation (“Wabash” or “the Company”) (NYSE: WNC). Investors who purchased Wabash securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Wabash has violated… read more